Non-invasive urine testing of EGFR activating mutation and T790M resistance mutation in non-small cell lung cancer

por Berz, David, Raymond, Victoria M., Garst, Jordan H., Erlander, Mark G.
Publicado en Exp Hematol Oncol (2016)

Urine test for EGFR analysis in patients with non-small cell lung cancer

por Franovic, Aleksandra, Raymond, Victoria M., Erlander, Mark G., Reckamp, Karen L.
Publicado en J Thorac Dis (2017)

Gene expression profiling of the tumor microenvironment during breast cancer progression

por Ma, Xiao-Jun, Dahiya, Sonika, Richardson, Elizabeth, Erlander, Mark, Sgroi, Dennis C
Publicado 2009

Performance and Clinical Evaluation of the 92-Gene Real-Time PCR Assay for Tumor Classification

por Erlander, Mark G., Ma, Xiao-Jun, Kesty, Nicole C., Bao, Lei, Salunga, Ranelle, Schnabel, Catherine A.
Publicado 2011

Molecular Profiling in Unknown Primary Cancer: Accuracy of Tissue of Origin Prediction

por Greco, F. Anthony, Spigel, David R., Yardley, Denise A., Erlander, Mark G., Ma, Xiao-Jun, Hainsworth, John D.
Publicado 2010

TOGA: An automated parsing technology for analyzing expression of nearly all genes

por Sutcliffe, J. Gregor, Foye, Pamela E., Erlander, Mark G., Hilbush, Brian S., Bodzin, Leon J., Durham, Jayson T., Hasel, Karl W.
Publicado 2000

Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer

por Jankowitz, Rachel C, Cooper, Kristine, Erlander, Mark G, Ma, Xiao-Jun, Kesty, Nicole C, Li, Hongying, Chivukula, Mamatha, Brufsky, Adam
Publicado 2011

Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer

por Giordano, Antonio, Liu, Yueying, Armeson, Kent, Park, Yeonhee, Ridinger, Maya, Erlander, Mark, Reuben, James, Britten, Carolyn, Kappler, Christiana, Yeh, Elizabeth, Ethier, Stephen
Publicado en PLoS One (2019)

Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli

por Peterson, Karin S., Huang, Jing-Feng, Zhu, Jessica, D’Agati, Vivette, Liu, Xuejun, Miller, Nancy, Erlander, Mark G., Jackson, Michael R., Winchester, Robert J.
Publicado 2004

High Expression of Stanniocalcin in Differentiated Brain Neurons

por Zhang, Ke-zhou, Westberg, Johan A., Paetau, Anders, von Boguslawsky, Kristina, Lindsberg, Perttu, Erlander, Mark, Guo, Hongqing, Su, Jeffrey, Olsen, Henrik S., Andersson, Leif C.
Publicado 1998

HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease

por Habel, Laurel A, Sakoda, Lori C, Achacoso, Ninah, Ma, Xiao-Jun, Erlander, Mark G, Sgroi, Dennis C, Fehrenbacher, Louis, Greenberg, Deborah, Quesenberry, Charles P
Publicado 2013

Ultrasensitive plasma ctDNA KRAS assay for detection, prognosis, and assessment of therapeutic response in patients with unresectable pancreatic ductal adenocarcinoma

por Chen, Inna, Raymond, Victoria M., Geis, Jennifer A., Collisson, Eric A., Jensen, Benny V., Hermann, Kirstine L., Erlander, Mark G., Tempero, Margaret, Johansen, Julia S.
Publicado en Oncotarget (2017)

Single-Cell Microarray Analysis in Hippocampus CA1: Demonstration and Validation of Cellular Heterogeneity

por Kamme, Fredrik, Salunga, Ranelle, Yu, Jingxue, Tran, Da-Thao, Zhu, Jessica, Luo, Lin, Bittner, Anton, Guo, Hong-Qing, Miller, Nancy, Wan, Jackson, Erlander, Mark
Publicado en J Neurosci (2003)

DNA Microarrays of the Complex Human Cytomegalovirus Genome: Profiling Kinetic Class with Drug Sensitivity of Viral Gene Expression

por Chambers, James, Angulo, Ana, Amaratunga, Dhammika, Guo, Hongqing, Jiang, Ying, Wan, Jackson S., Bittner, Anton, Frueh, Klaus, Jackson, Michael R., Peterson, Per A., Erlander, Mark G., Ghazal, Peter
Publicado 1999

Prediction of late distant recurrence in estrogen receptor positive breast cancer patients: prospective comparison of the Breast Cancer Index (BCI), Oncotype DX recurrence score, a...

por Sgroi, Dennis C., Sestak, Ivana, Cuzick, Jack, Zhang, Yi, Schnabel, Catherine A., Schroeder, Brock, Erlander, Mark G., Dunbier, Anita, Sidhu, Kally, Lopez-Knowles, Elena, Goss, Paul E., Dowsett, Mitch
Publicado 2013

Development and validation of a 32-gene prognostic index for prostate cancer progression

por Wu, Chin-Lee, Schroeder, Brock E., Ma, Xiao-Jun, Cutie, Christopher J., Wu, Shulin, Salunga, Ranelle, Zhang, Yi, Kattan, Michael W., Schnabel, Catherine A., Erlander, Mark G., McDougal, W. Scott
Publicado 2013

Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine

por Husain, Hatim, Melnikova, Vladislava O., Kosco, Karena, Woodward, Brian, More, Soham, Pingle, Sandeep C., Weihe, Elizabeth, Park, Ben Ho, Tewari, Muneesh, Erlander, Mark G., Cohen, Ezra, Lippman, Scott M., Kurzrock, Razelle
Publicado en Clin Cancer Res (2017)

BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease

por Janku, Filip, Vibat, Cecile Rose T., Kosco, Karena, Holley, Veronica R., Cabrilo, Goran, Meric-Bernstam, Funda, Stepanek, Vanda M., Lin, Patrick P., Leppin, Lorieta, Hassaine, Latifa, Poole, Jason C., Kurzrock, Razelle, Erlander, Mark G.
Publicado 2014

Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study

por Sgroi, Dennis C., Chapman, Judy-Anne W., Badovinac-Crnjevic, T., Zarella, Elizabeth, Binns, Shemeica, Zhang, Yi, Schnabel, Catherine A., Erlander, Mark G., Pritchard, Kathleen I., Han, Lei, Shepherd, Lois E., Goss, Paul E., Pollak, Michael
Publicado en Breast Cancer Res (2016)

BRAF(V600E) Mutations in High Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy

por Klempner, Samuel J., Gershenhorn, Bruce, Tran, Phu, Lee, Thomas K., Erlander, Mark G., Gowen, Kyle, Schrock, Alexa B., Morosini, Deborah, Ross, Jeffrey S., Miller, Vincent A., Stephens, Philip J., Ignatius Ou, Sai-Hong, Ali, Siraj M.
Publicado en Cancer Discov (2016)